Skip to content

Pacira BioSciences, Inc. PCRX Payments to Acquire Short-Term Investments

Payments to Acquire Short-Term Investments at other companies

Minerals Technologies logo
Minerals TechnologiesMTX
$1.3M-71.1%
Photronics logo
PhotronicsPLAB
$69.22M+150%
Equitable Holdings logo
Equitable HoldingsEQH
$8M-83.3%
DJT
Trump Media & Technology GroupDJT
$2.32M-63.3%
Playtika Holding Corp. logo
Playtika Holding Corp.PLTK
$0-100%
AMN Healthcare logo
AMN HealthcareAMN
$2.76M-87.3%

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$942.78M-14.5%
Enterprise value$1.21B+2.6%
P/E183.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%
Net margin0.7%
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s payments to acquire short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s payments to acquire short-term investments?
Pacira BioSciences, Inc. (PCRX) reported payments to acquire short-term investments of $0 in Q1 2026.
How has Pacira BioSciences, Inc.'s payments to acquire short-term investments changed year-over-year?
Pacira BioSciences, Inc.'s payments to acquire short-term investments decreased by 100.0% year-over-year, from $69.63M to $0.
What is the long-term trend for Pacira BioSciences, Inc.'s payments to acquire short-term investments?
Over 4 years (2021 to 2025), Pacira BioSciences, Inc.'s payments to acquire short-term investments has grown at a -30.7% compound annual growth rate (CAGR), from $611.49M to $141.04M.